Comparison of antiplatelet treatment in patients with clopidogrel nonresponders with or without carriage of CYP2C19 polymorphism

Article information

Korean J Intern Med. 2026;41(5):967-967

Publication date (electronic) : 2026 September 1

doi : https://doi.org/10.3904/kjim.2017.363.r1

Yun Myoung Ko ¹, Jeong Kyung Kim ², Jeong Hee Kim ², Sang-Ho Park ³, Rak Kyeong Choi ⁴

¹Department of Internal Medicine, Sun Hospital, Daejeon, Korea

²Cardiovascular Center, Department of Internal Medicine, Sun Hospital, Daejeon, Korea

³Department of Internal Medicine, Soonchunhyang University Hospital Cheonan, Cheonan, Korea

⁴Division of Cardiovascular, Department of Internal Medicine, Mediplex Sejong Hospital, Incheon, Korea

This retracted the article "Comparison of antiplatelet treatment in patients with clopidogrel nonresponders with or without carriage of CYP2C19 polymorphism ".

Korean J Intern Med 2018;kjim.2017.363

https://doi.org/10.3904/kjim.2017.363

This article has been retracted at the request of the authors.

We apologize for any inconvenience that may have caused.

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.